Yabao Pharmaceutical Group announced that the company plans to repurchase shares through centralized bidding transactions, with a total repurchase amount of not less than 0.1 billion yuan and not more than 0.15 billion yuan, for the purpose of cancellation and reducing registered capital. The repurchase period shall not exceed 6 months from the date of approval by the shareholders' meeting, and the repurchase price shall not exceed 6.95 yuan per share. The company stated that the repurchase will enhance investor confidence and protect the interests of shareholders.
亚宝药业：拟以1亿元至1.5亿元回购股份用于注销
Yabao Pharmaceutical Group: plans to repurchase shares with a total amount of 0.1 billion to 0.15 billion yuan for the purpose of cancellation.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated